Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Other Accumulated Expenses: 2012-2025

Historic Other Accumulated Expenses for Prothena Corp Public (PRTA) over the last 13 years, with Sep 2025 value amounting to $8.2 million.

  • Prothena Corp Public's Other Accumulated Expenses fell 42.61% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year decrease of 42.61%. This contributed to the annual value of $15.8 million for FY2024, which is 1.16% up from last year.
  • As of Q3 2025, Prothena Corp Public's Other Accumulated Expenses stood at $8.2 million, which was up 28.36% from $6.4 million recorded in Q2 2025.
  • Over the past 5 years, Prothena Corp Public's Other Accumulated Expenses peaked at $15.8 million during Q4 2024, and registered a low of $4.3 million during Q1 2021.
  • Moreover, its 3-year median value for Other Accumulated Expenses was $10.2 million (2023), whereas its average is $11.1 million.
  • Per our database at Business Quant, Prothena Corp Public's Other Accumulated Expenses surged by 78.73% in 2022 and then plummeted by 42.61% in 2025.
  • Prothena Corp Public's Other Accumulated Expenses (Quarterly) stood at $9.8 million in 2021, then climbed by 24.00% to $12.2 million in 2022, then climbed by 28.71% to $15.7 million in 2023, then increased by 1.16% to $15.8 million in 2024, then crashed by 42.61% to $8.2 million in 2025.
  • Its last three reported values are $8.2 million in Q3 2025, $6.4 million for Q2 2025, and $9.2 million during Q1 2025.